Wedge Capital Management’s Pediatrix Medical MD Stock Holding History

Wedge Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.14M	Buy	122,042 +12,932	+12%	+$341K	0.05%	254
2026 Q2	$2.76M	Sell	109,110 -21,750	-17%	-$495K	0.05%	277
2026 Q1	$2.8M	Buy	130,860 +6,810	+5%	+$142K	0.05%	275
2025 Q4	$2.65M	Sell	124,050 -14,178	-10%	-$291K	0.05%	302
2025 Q3	$2.32M	Buy	+138,228	New	+$2.07M	0.04%	325
2024 Q1	–	Sell	-81,988	Closed	-$762K	–	513
2023 Q4	$762K	Buy	81,988 +32,831	+67%	+$340K	0.01%	389
2023 Q3	$625K	Sell	49,157 -93,908	-66%	-$1.29M	0.01%	391
2023 Q2	$2.03M	Buy	143,065 +131,042	+1,090%	+$1.84M	0.03%	367
2023 Q1	$179K	Buy	+12,023	New	+$182K	﹤0.01%	415
2021 Q1	–	Sell	-10,658	Closed	-$262K	–	567
2020 Q4	$262K	Sell	10,658 -819	-7%	-$15.4K	﹤0.01%	485
2020 Q3	$187K	Sell	11,477 -6,179	-35%	-$115K	﹤0.01%	499
2020 Q2	$302K	Sell	17,656 -7,426	-30%	-$110K	﹤0.01%	422
2020 Q1	$292K	Buy	25,082 +6,389	+34%	+$132K	0.01%	402
2019 Q4	$519K	Buy	18,693 +677	+4%	+$17K	0.01%	391
2019 Q3	$408K	Sell	18,016 -15,352	-46%	-$350K	﹤0.01%	434
2019 Q2	$842K	Sell	33,368 -983,843	-97%	-$26.4M	0.01%	363
2019 Q1	$27.6M	Buy	1,017,211 +18,153	+2%	+$609K	0.32%	104
2018 Q4	$33M	Sell	999,058 -79,814	-7%	-$3.21M	0.41%	82
2018 Q3	$50.3M	Sell	1,078,872 -189,776	-15%	-$8.71M	0.48%	58
2018 Q2	$54.9M	Sell	1,268,648 -691,337	-35%	-$33.1M	0.54%	55
2018 Q1	$109M	Sell	1,959,985 -137,890	-7%	-$7.56M	1.05%	20
2017 Q4	$112M	Sell	2,097,875 -3,157	-0.2%	-$149K	1.01%	24
2017 Q3	$90.6M	Sell	2,101,032 -21,480	-1%	-$1.02M	0.84%	29
2017 Q2	$128M	Buy	2,122,512 +182,025	+9%	+$10.8M	1.23%	14
2017 Q1	$135M	Sell	1,940,487 -24,164	-1%	-$1.68M	1.29%	11
2016 Q4	$131M	Buy	1,964,651 +43,980	+2%	+$2.86M	1.27%	12
2016 Q3	$127M	Buy	1,920,671 +403,140	+27%	+$27.6M	1.28%	12
2016 Q2	$110M	Buy	+1,517,531	New	+$104M	1.14%	20

Other funds holding MD

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Hanseatic Management Services Albuquerque, New Mexico $122M AUM

Wedge Capital Management's MD Position: Q3 2026 in Review

Wedge Capital Management increased its Pediatrix Medical (MD) stake by 12% in Q3 2026, buying an estimated $341K and bringing the position to 122,042 shares worth $3.14M. The position accounts for 0.05% of the portfolio, ranked #254.

Wedge Capital Management first reported a position in MD in Q2 2016 and has held it in 28 quarters since. The position peaked at $135M in Q1 2017. 94 funds tracked by Wall St. Rank hold MD as of Q3 2026.

Wedge Capital Management held 122,042 shares of Pediatrix Medical worth $3.14M as of Q3 2026.
Wedge Capital Management bought 12,932 Pediatrix Medical shares in Q3 2026, an estimated $341K.
Pediatrix Medical made up 0.05% of Wedge Capital Management's portfolio in Q3 2026, its #254 holding.
Wedge Capital Management first reported a position in Pediatrix Medical in Q2 2016 and has held it in 28 quarters since.
Wedge Capital Management's Pediatrix Medical position peaked at $135M in Q1 2017.
94 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Wedge Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.